Patten & Patten’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-2,230
Closed -$243K – 238
2019
Q2
$243K Hold
2,230
– – 0.03% 220
2019
Q1
$249K Hold
2,230
– – 0.03% 211
2018
Q4
$215K Hold
2,230
– – 0.03% 213
2018
Q3
$272K Buy
2,230
+25
+1% +$2.94K 0.03% 211
2018
Q2
$242K Hold
2,205
– – 0.02% 218
2018
Q1
$235K Hold
2,205
– – 0.02% 220
2017
Q4
$235K Sell
2,205
-1,350
-38% -$144K 0.02% 224
2017
Q3
$395K Buy
3,555
+765
+27% +$81.8K 0.04% 194
2017
Q2
$288K Buy
+2,790
New +$275K 0.03% 209
2014
Q4
– Sell
-2,550
Closed -$233K – 213
2014
Q3
$233K Hold
2,550
– – 0.04% 190
2014
Q2
$218K Sell
2,550
-4,422
-63% -$348K 0.04% 195
2014
Q1
$549K Buy
+6,972
New +$581K 0.07% 181

Other funds holding IBB

Patten & Patten's IBB Position: Q3 2019 in Review

Patten & Patten sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,230 shares — an estimated $243K sold.

Patten & Patten first reported a position in IBB in Q1 2014 and held it in 12 quarters. The position peaked at $549K in Q1 2014. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Patten & Patten reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Patten & Patten sold 2,230 iShares Biotechnology ETF shares in Q3 2019, an estimated $243K.
  • Patten & Patten first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 12 quarters.
  • Patten & Patten's iShares Biotechnology ETF position peaked at $549K in Q1 2014.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Patten & Patten's 13F filing for Q3 2019, filed 15 Oct 2019.